Elizabeth C Scott

US Patent:

6451539, Sep 17, 2002

Filed:

Dec 22, 2000

Appl. No.:

09/748061

Inventors:

Michael Innis - Moraga CA
Elizabeth M. Scott - Sonoma CA

Assignee:

Chiron Corporation - Emeryville CA

International Classification:

C12Q 168

US Classification:

435 6, 435 71, 435 691, 4353201, 435325, 435455, 536 231, 536 241

Abstract:

Expression vectors and transfection systems providing high expression of a desired polypeptide are provided. Also provided are methods of using the expression vectors and transfection systems and mammalian cells modified by these compositions and methods.

US Patent:

20030064517, Apr 3, 2003

Filed:

May 13, 2002

Appl. No.:

10/146356

Inventors:

Michael Innis - Moraga CA, US
Elizabeth Scott - Sonoma CA, US

International Classification:

C12N015/86
C12N015/74

US Classification:

435/456000, 435/320100

Abstract:

Expression vectors and transfection systems providing high expression of a desired polypeptide are provided. Also provided are methods of using the expression vectors and transfection systems and mammalian cells modified by these compositions and methods.

US Patent:

20030215803, Nov 20, 2003

Filed:

Dec 7, 2001

Appl. No.:

10/012697

Inventors:

Pablo Garcia - San Francisco CA, US
Jaime Escobedo - Alamo CA, US
Altaf Kassam - Oakland CA, US
George Lamson - Moraga CA, US
Elizabeth Scott - Petaluma CA, US
Radoje Drmanac - Palo Alto CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Hollister CA, US
Snezana Drmanac - Palo Alto CA, US
Ivan Labat - Mountain View CA, US
Dena Leshkowitz - Kiryat Hasavionim, IL
David Kita - Milpitas CA, US
Veronica Garcia - Hayward CA, US
Lee Jones - Hayward CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06
C07K014/47
C07K016/40

US Classification:

435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 530/350000, 536/023200, 530/388100

Abstract:

This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostics and therapeutics comprising such novel human polynucleotides, their corresponding genes or gene products, including probes, antisense nucleotides, and antibodies. The polynucleotides of the invention correspond to a polynucleotide comprising the sequence information of at least one of SEQ ID NOS: 1-1477. The polypeptides of the invention correspond to a polypeptide comprising the amino acid sequence information of at least one of SEQ ID NOS: 1478-1568.

US Patent:

20050227917, Oct 13, 2005

Filed:

Feb 12, 2004

Appl. No.:

10/779543

Inventors:

Lewis Williams - Emeryville CA, US
Jaime Escobedo - Emeryville CA, US
Michael Innis - Emeryville CA, US
Pablo Garcia - Emeryville CA, US
Julie Sudduth-Klinger - Emeryville CA, US
Christoph Reinhard - Emeryville CA, US
Klaus Giese - Emeryville CA, US
Filippo Randazzo - Emeryville CA, US
Giulia Kennedy - Emeryville CA, US
David Pot - Emeryville CA, US
Altaf Kassam - Emeryville CA, US
George Lamson - Emeryville CA, US
Zhijun He - Emeryville CA, US
Elizabeth Scott - Emeryville CA, US
Guozhong Zhang - Emeryville CA, US
Theresa May - Emeryville CA, US
Doreen Sakamoto - Emeryville CA, US
Radoje Drmanac - Sunnyvale CA, US
Radomir Crkvenjakov - Sunnyvale CA, US
Mark Dickson - Sunnyvale CA, US
Snezana Drmanac - Sunnyvale CA, US
Ivan Labat - Sunnyvale CA, US
Dena Leshkowitz - Sunnyvale CA, US
David Kita - Sunnyvale CA, US
Veronica Garcia - Sunnyvale CA, US
Lee Jones - Sunnyvale CA, US

International Classification:

C12Q001/68
C07K014/47
A61K038/17
C07H021/04

US Classification:

514012000, 435006000, 435069100, 435320100, 435325000, 530350000, 536023500

Abstract:

The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.

US Patent:

20060234246, Oct 19, 2006

Filed:

Sep 2, 2004

Appl. No.:

10/934842

Inventors:

Elizabeth Scott - Emeryville CA, US
George Lamson - Emeryville CA, US
Altaf Kassam - Emeryville CA, US
Guozhong Zhang - Emeryville CA, US
Doreen Sakamoto - Emeryville CA, US
Pablo Garcia - Emeryville CA, US
Theresa May - Emeryville CA, US
Giulia Kennedy - Emeryville CA, US
Sanmao Kang - Emeryville CA, US
Christoph Reinhard - Emeryville CA, US
Ann Jefferson - Emeryville CA, US

International Classification:

C12Q 1/68
G01N 33/574
C07H 21/04
C12P 21/06
C07K 14/82
C07K 16/30

US Classification:

435006000, 435007230, 435069100, 435320100, 435325000, 530350000, 530388800, 536023500

Abstract:

The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.

US Patent:

20070243176, Oct 18, 2007

Filed:

Jul 7, 2003

Appl. No.:

10/615618

Inventors:

Jaime Escobedo - Alamo CA, US
Pablo Garcia - San Francisco CA, US
Julie Sudduth-Klinger - Kensington CA, US
Christoph Reinhard - Alameda CA, US
Filippo Randazzo - Oakland CA, US
George Lamson - Moraga CA, US
Elizabeth Scott - Sonoma CA, US
Guozhong Zhang - Fremont CA, US
Altaf Kassam - Oakland CA, US
David Pot - Arlington VA, US
Radoje Drmanac - Palo Alto CA, US
Ivan Labat - Mountain View CA, US

International Classification:

A61K 48/00
C07H 21/02
C07H 21/04
C07K 14/47
C07K 16/18
C12N 15/85
C12N 5/10
C12P 21/00
C12Q 1/68

US Classification:

424093210, 435320100, 435325000, 435006000, 435069100, 530350000, 530387900, 536023100

Abstract:

This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.

US Patent:

20110150911, Jun 23, 2011

Filed:

Nov 19, 2004

Appl. No.:

10/580050

Inventors:

Michael Houghton - Danville CA, US
Elizabeth Scott - Sonoma CA, US
Amy Weiner - Fairfield CA, US

International Classification:

A61K 39/12
C07K 14/175
C07K 1/14
C07K 1/16
C07K 1/18
C07H 21/04
C12Q 1/70
A61P 37/04
A61P 31/14

US Classification:

4241861, 4242041, 4241921, 530402, 530350, 530412, 530413, 530416, 530417, 536 243, 536 2433, 435 5

Abstract:

Immunogenic compositions for use in treating, preventing and diagnosing infection caused by the California (CAL) serotype of the genus , such as La Crosse virus (LACV), are disclosed. Also described are reagents for use in diagnostic assays.

US Patent:

63162539, Nov 13, 2001

Filed:

Dec 30, 1999

Appl. No.:

9/475460

Inventors:

Michael Innis - Moraga CA
Elizabeth M. Scott - Sonoma CA

Assignee:

Chiron Corporation - Emeryville CA

International Classification:

C12N 1565
C12N 516
C12N 510
C12P 2106

US Classification:

4353201

Abstract:

Expression vectors and transfection systems providing high expression of a desired polypeptide are provided. Also provided are methods of using the expression vectors and transfection systems and mammalian cells modified by these compositions and methods.